John Amory

Corporate Officer/Principal at University of Washington

57 year

Health Technology

Consumer Services

Profile

John A.
Amory is a Professor at the University of Washington, where he has been working since 2011.
He previously worked as a Director at Clarus Therapeutics, Inc. and as an Independent Director at Clarus Therapeutics Holdings, Inc. from 2021 to 2022.
Amory received a graduate degree from the University of Washington and a doctorate from the University of California, San Francisco.

John Amory active positions

Companies	Position	Start
University of Washington University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA.	Corporate Officer/Principal	30/06/2011

All active positions of John Amory

Former positions of John Amory

Companies	Position	End
CLARUS THERAPEUTICS HOLDINGS, INC.	Director/Board Member	30/10/2022
Clarus Therapeutics, Inc. Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL.	Director/Board Member	-

See the detail of John Amory's experience

Training of John Amory

University of Washington	Graduate Degree
The University of California, San Francisco	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Amory's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
CLARUS THERAPEUTICS HOLDINGS, INC.	Health Technology

Private companies	1
Clarus Therapeutics, Inc. Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL.	Health Technology